Esperion Therapeutics Inc.

NASDAQ:ESPR   3:59:55 PM EDT
26.89
-0.66 (-2.40%)
Debt Financing / Related, Equity Financing / Related

Esperion Announces Pricing Of Offering Of $250.0 Million Of Convertible Senior Subordinated Notes

Published: 11/12/2020 11:24 GMT
Esperion Therapeutics Inc (ESPR) - Esperion Announces Pricing of Offering of $250.0 Million of Convertible Senior Subordinated Notes.
Esperion Therapeutics Inc - Announced Pricing of $250.0 Million of 4.00% Convertible Senior Subordinated Notes Due 2025.
Esperion - Entered Prepaid Forward Stock Purchase Transaction, Will Purchase $55.0 Million of Stock for Settlement on Date That is Maturity Date of Notes.